Financial Daily from THE HINDU group of publications
Thursday, Jul 28, 2005


News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals


Dabur Pharma net rises 23 pc

Our Bureau

New Delhi , July 27

DABUR Pharma Ltd registered a 22.7 per cent jump in net profit, up from Rs 4.9 crore to Rs 6 crore, during the first quarter ended June 30, 2005.

The sales during the same period increased by 24.5 per cent, from Rs 58.8 crore to Rs 73.2 crore.

This has been achieved due to robust growth in overseas markets, with the CIS and Asia Pacific regions recording highest growth rates during the quarter.

"The company is on track in its R&D initiatives. It has completed private placement of 7.8 per cent equity shares to International Finance Corporation (IFC), at Rs 54 per share, during the quarter. This partnership with IFC will accelerate our growth," said Dr Anand Burman, Chairman, Dabur Pharma Ltd, in a statement.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
DCM Shriram Q1 net up at Rs 38.58 cr


Grasim clocks 15 pc increase in first quarter net profit
Bharat Forge net rises 60 pc
EIH Q1 net at Rs 6.55 cr
Higher refining margins push Reliance Ind Q1 net up 61 pc
ONGC Q1 net up 44 pc
Dabur Pharma net rises 23 pc
Indoco Remedies net rises 18 pc
Tata Steel net up 24 pc
Usha Martin net profit jumps 62%
Nava Bharat Ferro Q1 net down
LMC Q1 turnover down, profit up
Mico Q2 net down
IVRCL Infrastructure Q1 net up 59 pc
Ansal Properties Q1 net zooms
Sonata Software Q1 net rises 39 pc
Heavy provisions, loss on investments sale — Andhra Bank Q1 net falls to Rs 85 crore
Syndicate Bank Q1 net up 30 pc
SBM net dips to Rs 47 cr


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line